Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disseminated fusariosis emerged from prolonged local genital infection after cord blood transplantation.
Okada K, Endo T, Hashimoto D, Saga T, Ara T, Ogasawara R, Yasumoto A, Ibata M, Takahata M, Shigematsu A, Kondo T, Muraosa Y, Nomura T, Kanno-Okada H, Hashino S, Tanaka S, Kamei K, Teshima T. Okada K, et al. Among authors: ara t. J Infect Chemother. 2018 Aug;24(8):660-663. doi: 10.1016/j.jiac.2017.12.018. Epub 2018 Jan 17. J Infect Chemother. 2018. PMID: 29373264
Low-dose lenalidomide and dexamethasone therapy after melphalan-prednisolone induction in elderly patients with newly diagnosed multiple myeloma.
Onishi Y, Yokoyama H, Katsuoka Y, Ito T, Kimura T, Yamamoto J, Nakajima S, Sasaki O, Ara T, Minauchi K, Fukuhara O, Kobayashi N, Noji H, Ota S, Harigae H. Onishi Y, et al. Among authors: ara t. Ann Hematol. 2020 Oct;99(10):2351-2356. doi: 10.1007/s00277-020-04240-x. Epub 2020 Aug 31. Ann Hematol. 2020. PMID: 32865607 Clinical Trial.
Characterization of myeloid neoplasms following allogeneic hematopoietic cell transplantation.
Kuno M, Yamasaki S, Fujii N, Ishida Y, Fukuda T, Kataoka K, Uchida N, Katayama Y, Sato M, Onai D, Miyamoto T, Ota S, Yoshioka S, Ara T, Hangaishi A, Hashii Y, Onizuka M, Ichinohe T, Atsuta Y, Inamoto Y; on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group. Kuno M, et al. Among authors: ara t. Am J Hematol. 2022 Feb 1;97(2):185-193. doi: 10.1002/ajh.26401. Epub 2021 Nov 16. Am J Hematol. 2022. PMID: 34738245 Free article.
Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation.
Miyao K, Kuwatsuka Y, Murata M, Nagafuji K, Teshima T, Takeuchi Y, Shiratori S, Najima Y, Uchida N, Tanaka M, Sawa M, Ota S, Fukuda T, Ozawa Y, Kako S, Kawakita T, Ara T, Tanaka J, Kanda Y, Atsuta Y, Kanda J, Terakura S; GVHD Working Group and Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy. Miyao K, et al. Among authors: ara t. Transplant Cell Ther. 2022 Mar;28(3):153.e1-153.e11. doi: 10.1016/j.jtct.2021.12.009. Epub 2021 Dec 22. Transplant Cell Ther. 2022. PMID: 34954151 Free article.
Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation.
Iwasaki M, Kanda J, Tanaka H, Shindo T, Sato T, Doki N, Fukuda T, Ozawa Y, Eto T, Uchida N, Katayama Y, Kataoka K, Ara T, Ota S, Onizuka M, Kanda Y, Ichinohe T, Atsuta Y, Morishima S. Iwasaki M, et al. Among authors: ara t. Front Immunol. 2022 Mar 3;13:811733. doi: 10.3389/fimmu.2022.811733. eCollection 2022. Front Immunol. 2022. PMID: 35309307 Free PMC article.
Ideal Body Weight Is Useful For Predicting Neutrophil Engraftment and Platelet Recovery for Overweight and Obese Recipients in Single-Unit Cord Blood Transplantation.
Okada Y, Nakasone H, Konuma T, Uchida N, Tanaka M, Sugio Y, Aotsuka N, Nishijima A, Katsuoka Y, Ara T, Ota S, Onizuka M, Sawa M, Kimura T, Fukuda T, Atsuta Y, Kanda J, Kimura F. Okada Y, et al. Among authors: ara t. Transplant Cell Ther. 2022 Aug;28(8):504.e1-504.e7. doi: 10.1016/j.jtct.2022.05.006. Epub 2022 May 13. Transplant Cell Ther. 2022. PMID: 35577325 Free article.
Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades.
Nishiwaki S, Akahoshi Y, Morita-Fujita M, Shimizu H, Uchida N, Ozawa Y, Fukuda T, Tanaka M, Ikegame K, Ota S, Katayama Y, Takahashi S, Kawakita T, Ara T, Onizuka M, Kimura T, Tanaka J, Atsuta Y, Arai Y. Nishiwaki S, et al. Among authors: ara t. Blood Adv. 2022 Aug 9;6(15):4558-4569. doi: 10.1182/bloodadvances.2022008032. Blood Adv. 2022. PMID: 35737870 Free PMC article.
Adult patients with Ph+ ALL benefit from conditioning regimen of medium-dose VP16 plus CY/TBI.
Morita-Fujita M, Arai Y, Kondo T, Harada K, Uchida N, Toya T, Ozawa Y, Fukuda T, Ota S, Onizuka M, Kanda Y, Maruyama Y, Takada S, Kawakita T, Ara T, Ichinohe T, Kimura T, Atsuta Y, Kako S. Morita-Fujita M, et al. Among authors: ara t. Hematol Oncol. 2022 Dec;40(5):1041-1055. doi: 10.1002/hon.3046. Epub 2022 Jul 10. Hematol Oncol. 2022. PMID: 35790020 Free PMC article.
319 results